The COVID-19 pandemic has transformed vaccinology. Rapid deployment of mRNA
vaccines has saved countless lives. However, these platforms have inherent limitations …

Glycoconjugate vaccines have proven their worth in the protection and prevention of
infectious diseases. The introduction of the Haemophilus influenzae type b vaccine is the …

Sialyl Lewisa (sLea), also known as cancer antigen 19‐9 (CA19‐9), is a tumor‐associated
carbohydrate antigen. The overexpression of sLea on the surface of a variety of cancer cells …

Vibrio cholerae, a noninvasive mucosal pathogen, is endemic in more than 50 countries.
Oral cholera vaccines, based on killed whole-cell strains of Vibrio cholerae, can provide …

Opioid use disorder (OUD) has become a public health crisis, with recent significant
increases in the number of deaths due to overdose. Vaccination can provide an attractive …

No current methods can selectively elicit an antibody response to a specific conformational
epitope in a whole antigen in vivo. Here, we incorporated N ε-acryloyl-l-lysine (AcrK) or N ε …

Abstract Poly-β-(1–6)-N-acetylglucosamine (PNAG) is an important vaccine target,
expressed on many pathogens. A critical hurdle in developing PNAG based vaccine is that …

Vaccination has played a critical role in mitigating COVID-19. Despite the availability of
licensed vaccines, there remains a pressing need for improved vaccine platforms that …

Since the original discovery of bacteriophages by William Twort in 1915, and Félix d'Hérelle
in 1917, there have been numerous reports describing the use of these “filterable viruses” in …

The successful development of an anticancer vaccine will be a giant leap forward in cancer
prevention and treatment. Herein, the bacteriophage MX1 coat protein virus-like particles …